Claritev (CTEV) Non-Current Deffered Revenue (2020)

Claritev (CTEV) recorded quarterly Non-Current Deffered Revenue of $38.5 million in Q3 2020, little changed quarter-over-quarter from $38.5 million in Q2 2020.

Claritev (CTEV) Non-Current Deffered Revenue (2020) Analysis & Trends

Claritev's Non-Current Deffered Revenue history runs 1 years deep, the most recent figure standing at $38.5 million for Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn -
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn 4.57 Mn
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn -
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn -
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn 10.14 Mn
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn 400,000.00
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn 5.16 Mn
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn -
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn 63.07 Mn
10 Claritev 489.92 Mn 461.92 Mn 175.60 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2020 38.50 Mn
Jun 30, 2020 38.50 Mn
Mar 31, 2020 38.50 Mn